The Latest on: Gene patents
[google_news title=”” keyword=”gene patents” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Gene patents
- EY Announces Gene Sheridan of Navitas Semiconductor as an Entrepreneur Of The Year® 2024 Greater Los Angeles Award Finaliston May 8, 2024 at 5:53 am
Ernst & Young LLP (EY US) today announced that Gene Sheridan, CEO and co-founder of Navitas Semiconductor (Nasdaq:NVTS) was named an Entrepreneur Of The Year ® 2024 Greater Los Angeles Award finalist.
- Regeneron's experimental gene therapy improves hearing in one patienton May 8, 2024 at 3:15 am
Regeneron Pharmaceuticals said on Wednesday its investigational gene therapy improved hearing to normal levels in a child within 24 weeks in an early to mid-stage study.
- 5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dipon May 8, 2024 at 2:43 am
New drugs in development and a lack of significant patent cliffs ahead make this a great pharma stock to buy now and hold over the long run.
- Editas Medicine Announces First Quarter 2024 Results and Business Updateson May 8, 2024 at 12:00 am
The BRILLIANCE trial was the first in vivo CRISPR gene editing study in humans ... initiatives and business development activities as well as reduced legal and patent costs. The Editas Medicine ...
- Exclusive: Feng Zhang CRISPR startup gathers patents, locking up rights to family of editing techon May 7, 2024 at 4:00 am
In the bid to lock up patent rights to a growing suite of gene-editing technologies, Arbor Biotechnologies has acquired a small startup founded by MIT scientist and CRISPR pioneer Feng Zhang, the ...
- Research team develops fast-track process for genetic improvement of plant traitson May 6, 2024 at 12:10 pm
Researchers interested in improving a given trait in plants can now identify the genes that regulate the trait's expression without doing any experiments.
- Study reveals APOE4 gene duplication as a new genetic form of Alzheimer's diseaseon May 5, 2024 at 5:00 pm
A study led by researchers from the Dementia Neurobiology Group at the Sant Pau Research Institute, published today in the journal Nature Medicine, has identified that almost all individuals with two ...
- Livestock genome patent case rears head again with fresh court actionon April 30, 2024 at 11:05 pm
A long-running and controversial livestock genetics patent case has returned with five Australian industry groups including Meat & Livestock Australia now defending a new legal challenge in the ...
- Alnylam Pharmaceuticals gets grant for inhibiting expression of serum amyloid a geneon April 30, 2024 at 5:45 am
Discover the groundbreaking patent by Alnylam Pharmaceuticals Inc for a dsRNA molecule targeting Serum Amyloid A gene expression. Learn about the innovative design and potential applications in ...
via Bing News